Assessment of early and late dysphagia using videofluoroscopy and quality of life questionnaires in patients with head and neck cancer treated with radiation therapy

BackgorundThe aim of this study was to evaluate dysphagia in patients with head and neck cancer (HNC) undergoing three-dimensional conformal radiation therapy using objective and subjective tools simultaneously and to associate the clinical correlates of dysphagia with dosimetric parameters.MethodsTwenty patients were included in the study. The primary tumor and the involved lymph nodes (LN) were treated with 66-70 Gy, the uninvolved LN were treated with 46-50 Gy. Six swallowing structures were identified: the superior pharyngeal constrictor muscle (SPCM), the middle pharyngeal constrictor muscle (MPCM), the inferior pharyngeal constrictor muscle (IPCM), the base of tongue (BOT), the larynx and the proximal esophageal sphincter (PES). Dysphagia was evaluated using videofluoroscopy and European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire (QLQ-C30) and supplemental EORTC QoL module for HNC (QLQ-H&N35). The evaluations were performed before treatment, at 3 months and at 6 months following treatment.ResultsOn objective evaluation, the Dmax for the larynx and the sub-structures of the PCM were correlated with impaired lingual movement, BOT weakness and proximal esophageal stricture at 3 months, whereas the V65, the V70and the Dmax for the larynx was correlated with BOT weakness and the V65, the V70, the Dmax or the Dmean for the sub-structures of the PCM were correlated with impaired lingual movement, BOT weakness, reduced laryngeal elevation, reduced epiglottic inversion and aspiration at 6 months following treatment. On subjective evaluation, the V60, the Dmax and the Dmean for SPCM were correlated with QoL scores for HNSO at 3 months, whereas the V70 for SPCM were correlated with QoL scores for HNPA and the V60, the V65, the V70, the Dmax and the Dmean for SPCM were correlated with QoL scores for HNSO at 6 months following treatment.ConclusionsThe use of multiple dysphagia-related endpoints to complement eachother rather than to overlap with one another, as well as the use of multiple evaluations over time to represent a scale of early to late findings might provide a better insight in terms of the association of the clinical correlates of dysphagia with the dose-volume data for the dysphagia-related anatomical structures.

[1]  Sandra Nuyts,et al.  Radiation‐induced xerostomia in patients with head and neck cancer , 2006, Cancer.

[2]  P. Levendag,et al.  Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Dawson,et al.  Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[5]  L. van der Molen,et al.  Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[7]  C. W. Cummings,et al.  Cummings otolaryngology--head & neck surgery , 2010 .

[8]  Avraham Eisbruch,et al.  Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Meyers,et al.  Dysphagia following head and neck cancer surgery , 2004, Dysphagia.

[10]  K. Vineberg,et al.  Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? , 2004, International journal of radiation oncology, biology, physics.

[11]  P. Fayers,et al.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Butler,et al.  Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation , 2006, Head & neck.

[13]  D. Ronis,et al.  Clinical predictors of quality of life in patients with head and neck cancer. , 2004, Archives of otolaryngology--head & neck surgery.

[14]  Avraham Eisbruch,et al.  Radiation dose-volume effects in the larynx and pharynx. , 2010, International journal of radiation oncology, biology, physics.

[15]  A. Rademaker,et al.  Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. , 2003, International journal of radiation oncology, biology, physics.

[16]  F. Feng,et al.  Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. , 2007, International journal of radiation oncology, biology, physics.

[17]  Cai Grau,et al.  Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  E. Ward,et al.  Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer , 2013, Head & neck.

[19]  P. Vos,et al.  Dysphagia following chemoradiation for locally advanced head and neck cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  E. Glatstein Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation , 2008 .

[21]  J. Caudell,et al.  Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity‐modulated radiotherapy for head and neck cancer , 2014, Head & neck.